Cyprotex revenues in line with 2008



20 November 2009 @ 08:43 am BST

Drug discovery technology and information company Cyprotex current trading revenues are expected to be in line with 2008.

It said conditions remain challenging and in Q4, normally the strongest quarter, it had experienced lower than expected demand in general and from its largest customer.

But it said new business enquiries during the quarter had been more buoyant and the company remains cash generative with cash in hand at 31 October of £1.98m against £1.72m at the end of June.

Story provided by Business Financial Newswire

© 2010 Stockmarketwire.com. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

    Click!
  • Rate this article:

Comments

Post Your Comment

*Name


Most Popular Markets

 
 
IBTimes © 2012 IBTimes Company. All Rights Reserved. Partners